相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas
Asako Kukita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends
Edoardo Fabini et al.
FUTURE MEDICINAL CHEMISTRY (2019)
SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway
Hailiang Ren et al.
ONCOTARGETS AND THERAPY (2019)
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
Michael J. Thomenius et al.
PLOS ONE (2018)
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
Linda Xiaoyan Li et al.
CELL DEATH & DISEASE (2018)
SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
Bradley J. Toghill et al.
CLINICAL EPIGENETICS (2018)
Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
Shan-Ru Zuo et al.
JOURNAL OF CANCER (2018)
A motif in HSP90 and P23 that links molecular chaperones to efficient estrogen receptor α methylation by the lysine methyltransferase SMYD2
Wolfgang M. J. Obermann
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
SMYD2 glutathionylation contributes to degradation of sarcomeric proteins
Dhanushka N. P. Munkanatta Godage et al.
NATURE COMMUNICATIONS (2018)
Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma
Wenchao Xu et al.
MEDICAL SCIENCE MONITOR (2018)
Bisphenol A and Phthalates Modulate Peritoneal Macrophage Function in Female Mice Involving SYMD2-H3K36 Dimethylation
Quanxi Li et al.
ENDOCRINOLOGY (2018)
Inhibitors of Protein Methyltransferases and Demethylases
H. Umit Kaniskan et al.
CHEMICAL REVIEWS (2018)
The Smyd family of methyltransferases: role in cardiac and skeletal muscle physiology and pathology
Christopher M. Tracy et al.
CURRENT OPINION IN PHYSIOLOGY (2018)
Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci
Gregory T. Jones et al.
CIRCULATION RESEARCH (2017)
The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling
Shuman Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease
Linda Xiaoyan Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective
A. Crucean et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
MEMBRANE AND NUCLEAR ESTROGEN RECEPTOR ALPHA ACTIONS: FROM TISSUE SPECIFICITY TO MEDICAL IMPLICATIONS
Jean-Francois Arnal et al.
PHYSIOLOGICAL REVIEWS (2017)
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress
Adi Zipin-Roitman et al.
ONCOTARGET (2017)
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression
Debora Basile et al.
CANCER TREATMENT REVIEWS (2017)
Protein arginine methylation: a prominent modification and its demethylation
Juste Wesche et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells
Rui Wang et al.
CANCER SCIENCE (2017)
SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency
Daniela Boehm et al.
CELL HOST & MICROBE (2017)
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
Nicolas Reynoird et al.
GENES & DEVELOPMENT (2016)
SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas
Rie Ohtomo-Oda et al.
HUMAN PATHOLOGY (2016)
Conformational Dynamics of Lysine Methyltransferase Smyd2. Insights into the Different Substrate Crevice Characteristics of Smyd2 and Smyd3
Balasubramanian Chandramouli et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors
Scott D. Cowen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
Erik Eggert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
An Integrative Proteomic Approach Identifies Novel Cellular SMYD2 Substrates
Hazem Ahmed et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics
Jonathan B. Olsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia
Wilson Oliveira-Santos et al.
TUMOR BIOLOGY (2016)
Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis
Sevgi Bagislar et al.
ONCOTARGET (2016)
Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice
Jia Qi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication
Ana Silvia Pires-Luis et al.
EPIGENETICS (2015)
Structure and Function of SET and MYND Domain-Containing Proteins
Nicholas Spellmon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The Histone Methyltransferase Smyd2 Is a Negative Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6) and Tumor Necrosis Factor α (TNF-α) Production
Guiliang Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
Hannah Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2
Ramzi F. Sweis et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN
Makoto Nakakido et al.
NEOPLASIA (2015)
Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
S. Komatsu et al.
BRITISH JOURNAL OF CANCER (2015)
The Selective Activation of p53 Target Genes Regulated by SMYD2 in BIX-01294 Induced Autophagy-Related Cell Death
Jia-Dong Fan et al.
PLOS ONE (2015)
Molecular Dynamics Simulation Reveals Correlated Inter-Lobe Motion in Protein Lysine Methyltransferase SMYD2
Nicholas Spellmon et al.
PLOS ONE (2015)
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Ryuji Hamamoto et al.
NATURE REVIEWS CANCER (2015)
SMYD Proteins: Key Regulators in Skeletal and Cardiac Muscle Development and Function
Shao Jun Du et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2014)
Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis
Amna Sajjad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation
Ryuji Hamamoto et al.
CANCER LETTERS (2014)
Structural Insights into Estrogen Receptor α Methylation by Histone Methyltransferase SMYD2, a Cellular Event Implicated in Estrogen Signaling Regulation
Yuanyuan Jiang et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor
Luis Henrique Toshihiro Sakamoto et al.
LEUKEMIA RESEARCH (2014)
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
Pawel K. Mazur et al.
NATURE (2014)
The Histone Methyltransferase SMYD2 Methylates PARP1 and Promotes Poly (ADP-ribosyl)ation Activity in Cancer Cells
Lianhua Piao et al.
NEOPLASIA (2014)
Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function
Tobias Voelkel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
SMYD2 is induced during cell differentiation and participates in early development
Borja Sese et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2013)
Regulation of estrogen receptor a by histone methyltransferase SMYD2-mediated protein methylation
Xi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Polycomb Repressive Complex 2 Regulates Normal Development of the Mouse Heart
Aibin He et al.
CIRCULATION RESEARCH (2012)
Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization
Laura T. Donlin et al.
GENES & DEVELOPMENT (2012)
Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis
Paul Delgado-Olguin et al.
NATURE GENETICS (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation
Hyun-Soo Cho et al.
NEOPLASIA (2012)
Biochemical Characterization of Human SET and MYND Domain-Containing Protein 2 Methyltransferase
Jiaquan Wu et al.
BIOCHEMISTRY (2011)
Breast cancer statistics, 2011
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Structure of Human SMYD2 Protein Reveals the Basis of p53 Tumor Suppressor Methylation
Li Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Crystal Structures of Histone and p53 Methyltransferase SmyD2 Reveal a Conformational Flexibility of the Autoinhibitory C-Terminal Domain
Yuanyuan Jiang et al.
PLOS ONE (2011)
Smyd3 Is Required for the Development of Cardiac and Skeletal Muscle in Zebrafish
Tomoaki Fujii et al.
PLOS ONE (2011)
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Andrew D. Ferguson et al.
STRUCTURE (2011)
Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins
Shutong Xu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
SET/MYND Lysine Methyltransferases Regulate Gene Transcription and Protein Activity
Kristin Leinhart et al.
GENES (2011)
Crystal Structure of Cardiac-specific Histone Methyltransferase SmyD1 Reveals Unusual Active Site Architecture
Nualpun Sirinupong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Louis A. Saddic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cardiac Deletion of Smyd2 Is Dispensable for Mouse Heart Development
Florian Diehl et al.
PLOS ONE (2010)
Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma
Shuhei Komatsu et al.
CARCINOGENESIS (2009)
The tale of two domains - Proteomics and genomics analysis of SMYD2, a new histone methyltransferase
Mohamed Abu-Farha et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity
Yizhou Liu et al.
CANCER CELL (2007)
Repression of p53 activity by Smyd2-mediated methylation
Jing Huang et al.
NATURE (2006)
Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
Mark A. Brown et al.
MOLECULAR CANCER (2006)
The SET-domain protein superfamily: protein lysine methyltransferases
SC Dillon et al.
GENOME BIOLOGY (2005)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis
PD Gottlieb et al.
NATURE GENETICS (2002)
Regulation of chromatin structure by site-specific histone H3 methyltransferases
S Rea et al.
NATURE (2000)
分享论文
